Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 58417-58418 [06-8443]
Download as PDF
<![CDATA[
58417
Federal Register / Vol. 71, No. 191 / Tuesday, October 3, 2006 / Notices
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, call the
HRSA Reports Clearance Officer on
301–443–1129
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, utilizing automated
collection techniques or other forms of
information technology.
Proposed Project: HRSA AIDS
Education and Training Centers
Evaluation Activities (OMB No. 0915–
0281)—Revision
The AIDS Education and Training
Centers (AETC) Program, under the
Ryan White Comprehensive AIDS
Resources Emergency (CARE) Act,
supports a network of regional and
cross-cutting national centers that
conduct targeted, multi-disciplinary
education and training programs for
health care providers treating persons
with HIV/AIDS. The purpose of the
AETCs is to increase the number of
health care providers who are
effectively educated and motivated to
counsel, diagnose, treat, and medically
manage individuals with HIV infection,
and to help prevent high risk behaviors
that lead to HIV transmission.
As part of an ongoing evaluation effort
of AETC activities, information is
needed on AETC training sessions,
consultations, and technical assistance
activities. Each regional center collects
forms on AETC training events, and
centers are required to report aggregate
data on their activities to HRSA and the
Number of
respondents
Form
Responses
per respondent
HIV/AIDS Bureau (HAB). This data
collection provides information on the
number of training events, including
clinical trainings and consultations, as
well as technical assistance activities
conducted by each regional center, the
number of health care providers
receiving professional training or
consultation, and the time and effort
expended on different levels of training
and consultation activities. In addition,
information is obtained on the
populations served by the AETC
trainees, and the increase in capacity
achieved through training events.
Collection of this information allows
HRSA/HAB to provide information on
training activities, types of education,
and training provided to Ryan White
CARE Act grantees, resource allocation,
and capacity expansion.
Trainees are asked to complete the
Participant Information Form (PIF) for
each activity they complete, and trainers
are asked to complete the Event Record
(ER). The estimated annual response
burden to trainers as well as attendees
of training programs is as follows:
Total
responses
Hours per
response
Total burden
hours
PIF ........................................................................................
ER ........................................................................................
94,641
16,417
1
1
94,641
16,417
0.2
0.2
18,928.2
3,283
Total ..............................................................................
111,058
........................
111,058
........................
22,211.2
The estimated annual burden to
AETCs is as follows:
Number of respondents
Responses
per respondent
Total Responses
Hours per response
Total burden
hours
12
2
24
32
768
Aggregate Data Set .............................................................
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 25, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–16295 Filed 10–2–06; 8:45 am]
rwilkins on PROD1PC63 with NOTICES
The total burden hours are 22,979.2.
Send comments to Susan G. Queen,
PhD., HRSA Reports Clearance Officer,
Room 10–33 Parklawn Building, 5600
Fishers Lane, Rockville, Maryland
20857. Written comments should be
received within 60 days of this notice.
Pursuant to Public Law 92–463,
notice is hereby given of the eleventh
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8:30 a.m. to approximately 5 p.m. on
Monday, November 13, 2006 and 8:30
a.m. to approximately 5 p.m. on
Tuesday, November 14, 2006, at the
Marriott Inn and Conference Center,
BILLING CODE 4165–15–P
VerDate Aug<31>2005
19:59 Oct 02, 2006
Jkt 211001
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
University of Maryland-College Park,
3501 University Boulevard East,
Adelphi, MD 20783. The meeting will
be open to the public with attendance
limited to space available. The meeting
also will be Web cast.
The agenda topics include:
Consideration of public comments on
and finalization of the Committee’s draft
report, Policy Issues Associated With
Undertaking a Large U.S. Population
Cohort Project on Genes, Environment
and Disease; a review of the
Committee’s draft report on
pharmacogenomics; a session related to
the impact of gene patents and licensing
practices on patient access to genetic
and genomic technologies; and updates
on developments at FDA and CMS
E:\FR\FM\03OCN1.SGM
03OCN1
58418
Federal Register / Vol. 71, No. 191 / Tuesday, October 3, 2006 / Notices
regarding the oversight of genetic tests
and services and on other Federal
activities relevant to the work and
charter of SACGHS.
Time will be provided each day for
public comments. The Committee
would welcome hearing from anyone
wishing to provide public comment on
any issue related to genetics, health and
society. Individuals who would like to
provide public comment should notify
the SACGHS Executive Secretary, Ms.
Sarah Carr, by telephone at 301–496–
9838 or e-mail at sc112c@nih.gov. The
SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda,
MD 20892. Anyone planning to attend
the meeting, who is in need of special
assistance, such as sign language
interpretation or other reasonable
accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: September 26, 2006.
Anna Snouffer,
Acting Director, NIH Office of Federal
Advisory Committee Policy.
[FR Doc. 06–8443 Filed 10–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rwilkins on PROD1PC63 with NOTICES
National Cancer Institute; Notice of
Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (4 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Cancer Institute Board of
Scientific Advisors.
The meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
VerDate Aug<31>2005
20:53 Oct 02, 2006
Jkt 208001
Name of Committee: National Cancer
Institute Board of Scientific Advisors,
TARGET Ad Hoc Subcommittee.
Date: November 1, 2006.
Time: 6 p.m. to 10 p.m.
Agenda: To discuss activities related to the
BSA TARGET Ad Hoc Subcommittee.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Malcolm M. Smith,
Executive Secretary, Pediatric Section,
Clinical Investigation Branch, Clinical
Therapy Evaluation Program, NCI, 6130
Executive Blvd., Bethesda, MD 20852, 301–
496–2522, smithm@ctep.nci.nih.gov.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: November 2–3, 2006.
Time: November 2, 2006, 8 a.m. to 6 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Review
Group(s); and Budget Presentation; Reports of
Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Time: November 3, 2006, 8:30 a.m. to 1
p.m.
Agenda: Reports of Special Initiatives; RFA
and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Paulette S. Gray, PhD.,
Executive Secretary, Director, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, RM. 8001,
Bethesda, MD 20892, 301–496–5147,
grayp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8450 Filed 10–2–06; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel,
Biomedical and Behavioral Research
Facilities.
Date: October 11, 2006.
Time: 12 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Steven Birken, PhD,
Scientific Review Administrator, National
Institutes of Health, National Center for
Research Resources, Office of Review, 6701
Democracy Blvd., 1 Democracy Plaza, Room
1078, Bethesda, MD 20892, 301–435–0815,
birkens@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Center for
Research Resources Special Emphasis Panel,
Washington NPRC.
Date: October 24–26, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel—Seattle, 1113
Sixth Avenue, Carlsbad Room, Seattle, WA
98101.
Contact Person: Carol Lambert, PhD,
Scientific Review Administrator, Office of
Review, National Center for Research
Resources, National Institutes of Health, 6701
Democracy Blvd., 1 Democracy Plaza, Room
1076, Bethesda, MD 20892, 301–435–0814,
lambert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS)
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 71, Number 191 (Tuesday, October 3, 2006)]
[Notices]
[Pages 58417-58418]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8443]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the
eleventh meeting of the Secretary's Advisory Committee on Genetics,
Health, and Society (SACGHS), U.S. Public Health Service. The meeting
will be held from 8:30 a.m. to approximately 5 p.m. on Monday, November
13, 2006 and 8:30 a.m. to approximately 5 p.m. on Tuesday, November 14,
2006, at the Marriott Inn and Conference Center, University of
Maryland-College Park, 3501 University Boulevard East, Adelphi, MD
20783. The meeting will be open to the public with attendance limited
to space available. The meeting also will be Web cast.
The agenda topics include: Consideration of public comments on and
finalization of the Committee's draft report, Policy Issues Associated
With Undertaking a Large U.S. Population Cohort Project on Genes,
Environment and Disease; a review of the Committee's draft report on
pharmacogenomics; a session related to the impact of gene patents and
licensing practices on patient access to genetic and genomic
technologies; and updates on developments at FDA and CMS
[[Page 58418]]
regarding the oversight of genetic tests and services and on other
Federal activities relevant to the work and charter of SACGHS.
Time will be provided each day for public comments. The Committee
would welcome hearing from anyone wishing to provide public comment on
any issue related to genetics, health and society. Individuals who
would like to provide public comment should notify the SACGHS Executive
Secretary, Ms. Sarah Carr, by telephone at 301-496-9838 or e-mail at
sc112c@nih.gov. The SACGHS office is located at 6705 Rockledge Drive,
Suite 750, Bethesda, MD 20892. Anyone planning to attend the meeting,
who is in need of special assistance, such as sign language
interpretation or other reasonable accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic and genomic technologies and, as
warranted, to provide advice on these issues. The draft meeting agenda
and other information about SACGHS, including information about access
to the Web cast, will be available at the following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: September 26, 2006.
Anna Snouffer,
Acting Director, NIH Office of Federal Advisory Committee Policy.
[FR Doc. 06-8443 Filed 10-2-06; 8:45 am]
BILLING CODE 4140-01-M
